share_log

Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) | SC 13D: Statement of acquisition of beneficial ownership by individuals-CLS Therapeutics Ltd.(9.7%),Dmitry Genkin(9.7%), etc.

XENETIC BIOSCIENCES INC C/WTS 11/07/2024 (TO PUR COM) | SC 13D:超过5%持股股东披露文件-CLS Therapeutics Ltd.(9.7%),Dmitry Genkin(9.7%)等

美股SEC公告 ·  2023/06/15 14:20
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息